PRZOOM - /newswire/ -
Noida, Uttar Pradesh, India, 2011/10/10 - A new report from IMARC Group suggests that an increased research and development into technologies that nullify the need of cold chains could restrain the growth of the global cold chain logistics industry - IMARCgroup.com.
A new report from IMARC Group entitled “Global Healthcare Cold Chain Logistics Market Report & Forecast (2011-2016)” finds that research and development into technologies that can nullify the requirement of cold chains pose a major threat in the growth of the global cold chain logistic services market. The report finds that large scale initiatives are currently being undertaken to develop products that are heat / freeze stable. In July 2009, a report in Vaccine magazine detailed a new hepatitis B vaccine that remains stable even after repeated freezing at -20°C and when stored for 12 months at 37°C. Similarly, in February 2010, Science Translational Medicine magazine featured an article on using sucrose and trehalose as stabilizing agents and cryoprotectants for biological products. The report finds that a number of companies currently have thermostable vaccines in their pipelines. Variation biotechnologies, for example, is currently developing vaccines for Influenza, Measles, Hepatitis A, Shigella and CMV. Similarly, Altravax is currently developing thermostable Rabies vaccines.
IMARC’s new report entitled “Global Healthcare Cold Chain Logistics Market Report & Forecast (2011-2016)” provides an analytical and statistical insight into the logistic opportunities in the global healthcare market. The study that has been undertaken using both desk based as well as qualitative primary market research has analyzed three aspects of the global healthcare cold chain logistics market.
The first aspect involves the quantification of the global market for temperature sensitive healthcare products into three major classes and evaluation of the current and future opportunities in each of these classes. The second aspect involves an in-depth understanding on the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. The third aspect involves the quantification of the global healthcare cold chain logistic services market and a comprehensive evaluation of its various segments.
What we have achieved in this report:
Comprehensive Market Analysis of Temperature Sensitive Healthcare Products:
Classes Covered: Biopharmaceuticals, Vaccines & Clinical Trial Material
Focus of the Analysis in Each Class:
• Drivers and challenges;
• Historical sales trends;
• Logistic requirements;
• Impact of temperature excursions;
• Opportunities in cold chain services;
• Market outlook (2011-2016);
Understanding the Operations of a Healthcare Cold Chain Distribution Process.
Focus of the Analysis:
• Understanding the various methods of cold chain distribution and their advantages/disadvantages.
• Understanding the cold chain requirements for various temperature sensitive healthcare products and the impact of temperature excursions.
• Understanding the various costs involved in cold chain transportation and comparing it with non-cold chain transportation.
• Understanding the key steps required in the setting and organization of an efficient cold chain distribution process.
• Comprehensive Market Analysis of the Healthcare Cold Chain Logistic Services Market.
Focus of the analysis:
• Quantifying the global healthcare cold chain logistic services market;
• Quantifying the market size by product;
• Quantifying the market size by service;
• Quantifying the market size by region.
Information has been sourced from both primary and secondary sources:
Primary sources include industry surveys and face to face/telephone interviews with industry experts.
Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, industry portals, government sources and access to more than 4000 paid databases.
Table of Contents:
1 Research Methodology & Market Definitions
2 Executive Summary
3 The Global Healthcare Cold Chain Logistics Market
3.1 Current Trends
3.1.1 Healthcare Cold Chain Products are Exhibiting Exponential Growth
3.1.2 Temperature Sensitive Healthcare Products Have Well Defined Logistic Needs
3.1.3 Outsourcing Trends in Research & Manufacturing Have Increased Logistic Demands
3.1.4 Increasing Regulatory Focus on the Integrity of Transported Healthcare Products
3.1.5 Cost is Not Always the Most Important Driver in Supplier Decisions
4 The Global Healthcare Cold Chain Products Market
4.1 Current Market Trends & Forecast
4.2 Market Segments
18.104.22.168 Current Market Trends & Forecast
22.214.171.124 Cold Chain Requirements for Biopharmaceuticals
126.96.36.199 Cold Chain Opportunities for Biopharmaceuticals
188.8.131.52 Current Market Trends & Forecast
184.108.40.206 Cold Chain Requirements for Vaccines
220.127.116.11 Cold Chain Opportunities for Vaccines
4.2.3 Clinical Trial Materials
18.104.22.168 Current Market Trends & Forecast
22.214.171.124 Cold Chain Requirements for Clinical Trial Materials
126.96.36.199 Cold Chain Opportunities for Clinical Trial Materials
5 Healthcare Cold Chain Logistics: How Does It Operate?
5.1 Cold Chain Packaging & Transportation Methods
5.1.1 Dry Ice
5.1.2 Liquid Nitrogen
5.1.3 Gel Packs
5.2 Modeling the Cost of Cold Chain Packaging & Transportation
5.3 The Setting & Organization of Cold Chains
5.3.1 Initial Considerations
5.3.2 Choosing the Correct Model
5.3.3 Regulatory/Custom Clearance
5.3.4 Final Stages
5.3.5 Quality Assurance
6 The Healthcare Cold Chain Logistic Services Market
6.1 Current Trends & Forecast
6.2 Market Segmentation
6.2.1 Market by Product
188.8.131.52 Biopharmaceuticals & Vaccines
184.108.40.206 Clinical Trial Materials
6.2.2 Market by Service
220.127.116.11 Packaging & Instrumentation
6.2.3 Market by Region
18.104.22.168 North America
22.214.171.124 Asia Pacific
126.96.36.199 Rest of the World
7 Challenges in the Healthcare Cold Chain Logistics Market
7.1 Cold Chain Infrastructure Remains Underdeveloped in Many Regions
7.2 Lack of Funding to Implement an Efficient Cold Chain Infrastructure
7.3 New Technologies Nullifying the Need of Cold Chains
8 Key Company Profiles
8.1 World Courier
8.4 United Parcel Service
8.5 Kuehne and Nagel
8.6 Cavalier Logistics
8.7 DB Schenker
8.8 Life ConEx
8.9 American Airlines Cargo
8.10 Continental Air Cargo
To buy the complete report or to get a free sample:
Call: +91-120-425-6531 (Asia), +1-631-791-1145 (America)
For more information please visit imarcgroup.com/.